FGB and COVID-19: In our study, the risk of severe COVID-19 is lower in minor A-allele carriers of the FGB rs1800790 gene, which, in our opinion, is due to a higher level of fibrinogen in these patients, which inhibits/limits the spread of SARS-CoV-2 infection and is generally consistent with the literature data [26,27].